Surya Pharmaceutical Financials

NSE: SURYAPHARM | BSE: 532516

₹0.16

up-down-arrow-0.01 (-5.88%)

As on 14-Sep-2015IST

Market cap

info icon

₹3 Cr

Revenue (TTM)

info icon

₹3 Cr

P/E Ratio

info icon

0

P/B Ratio

info icon

-0

Div. Yield

info icon

0 %

loading...

Income Statement (₹ Cr)

TTM Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04
Operating Revenue
2.60
60.33
1,622.95
1,600.42
1,134.14
722.92
Total Income
--
61.18
1,627.58
1,603.89
1,144.63
727.68
Total Expenditure
49.09
232.59
1,807.65
1,337.87
971.25
606.38
EBITDA
-46.48
-172.26
-184.70
262.54
162.88
116.54
Depreciation
--
62.47
34.62
26.55
20.55
16.05
EBIT
-77.72
-234.73
-219.32
236.00
142.33
100.50
Interest
107.91
206.90
178.54
107.75
62.36
41.16
Other Income
--
0.85
4.63
3.47
10.50
4.76
Exceptional Items
--
-17.93
--
--
--
--
Profit before Tax
-185.18
-458.71
-393.22
131.72
90.46
64.10
Provision for Tax
--
-156.90
-120.07
31.56
14.40
7.97
Profit after Tax
258.68
-301.81
-273.16
100.16
76.06
56.13

Liabilities (₹ Cr)

TTM Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04
Shareholder's Funds
-776.29
-54.33
247.48
519.95
303.19
230.11
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
186.62
35.43
141.69
331.28
721.33
514.91
Current Liabilities
2,132.86
1,790.83
1,637.12
1,314.60
361.92
203.83
Total Liabilities
1,543.19
2,017.48
2,127.66
2,165.83
1,386.44
948.85

Assets (₹ Cr)

TTM Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04
Non-Current Assets
1,413.66
803.02
854.99
657.95
433.48
301.03
Current Assets
128.16
968.90
1,171.30
1,507.87
950.90
646.98
Total Assets
1,543.20
2,017.48
2,127.66
2,165.83
1,386.44
948.85
Total Debt*
--
2,009.07
1,754.17
1,441.22
708.11
500.73
Net Current Assets
-2,004.70
-821.93
-465.82
193.27
588.98
443.15
Contingent Liabilities
--
266.81
175.77
184.45
108.65
57.71

Cashflow (₹ Cr)

TTM Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04
Cash From Operating Activities
--
165.55
385.56
68.93
165.31
-8.10
Cash Flow from Investing Activities
--
-7.90
-149.98
-245.00
-144.32
-120.66
Cash from Financing Activities
--
-160.30
-241.17
173.64
-11.32
103.26
Net Cash Inflow / Outflow
--
-2.65
-5.60
-2.43
9.68
-25.49

Financials Ratios

TTM Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04
Adjusted EPS (₹) info
12.76
-14.89
-13.47
5.20
5.26
3.88
Cash EPS (₹) info
--
-11.80
-11.76
6.57
6.68
4.99
Adjusted Book Value (₹) info
--
-2.68
12.21
26.63
20.81
15.85
Dividend per Share (₹) info
--
--
--
0.15
0.15
0.12
Cash Flow per Share (₹) info
--
8.17
19.02
3.58
114.26
-5.60
Free Cash Flow per Share (₹) info
--
3.82
9.47
-14.50
-30.91
-111.92

Profitability Ratios

TTM Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04
ROCE (%) info
--
-12.73
-10.84
16.12
17.57
17.17
ROE (%) info
--
-312.51
-71.80
24.59
28.68
27.57
ROA (%) info
14.53
-15.89
-13.03
5.64
6.51
7.15
EBIT Margin (%) info
-2,984.56
-389.07
-13.51
14.75
12.55
13.90
Net Margin (%) info
9,933.76
-493.33
-16.78
6.24
6.64
7.71
Cash Profit Margin (%) info
--
-370.38
-14.46
7.76
8.35
9.60

Growth Ratios

TTM Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04
Revenue Growth (%) info
-82.33
-96.28
1.41
41.11
56.88
48.59
EBIT Growth (%) info
90.42
-7.03
-192.93
65.81
41.62
30.14
Net Profit Growth (%) info
120.97
-10.49
-372.72
31.68
35.51
34.56
EPS Growth (%) info
120.97
-10.49
-359.27
-1.16
35.51
34.55
Book Value Growth (%) info
--
-121.95
-51.79
70.49
31.34
28.89

Valuation Ratios

TTM Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04
Price / Earnings info
0.01
--
--
4.71
0.34
0.14
Price / Book Value info
0.00
-0.43
0.89
0.92
0.85
0.34
Dividend Yield (%) info
--
--
--
0.61
0.85
2.25
EV/EBITDA info
-40.86
-11.81
-10.90
7.13
5.46
4.70
Close Price (₹) info
0.21
1.20
10.80
24.05
17.65
5.36
High Price (₹) info
1.93
12.20
29.00
35.68
18.90
12.98
Low Price (₹) info
0.21
1.15
9.40
16.19
5.31
4.66
Market Cap (₹ Cr) info
3.24
23.32
219.38
472.24
256.16
77.26

Solvency Ratios

TTM Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04
Debt to Equity info
-0.21
-36.98
7.09
2.81
2.35
2.18
Short term debt to equity ratio info
-2.39
-29.86
5.80
2.13
--
--
Current Ratio info
0.06
0.54
0.72
1.15
2.63
3.17
Quick Ratio info
0.06
0.19
0.22
0.36
0.81
1.34
Interest Coverage info
-0.72
-1.22
-1.20
2.22
2.45
2.56

Operating Efficiency Ratios

TTM Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04
Debtors to sales (%) info
213.29
372.95
14.55
18.17
13.50
18.99
Asset Turnover info
0.00
0.03
0.79
0.92
0.99
0.96
Receivable days info
--
1,302.53
58.29
49.60
45.78
53.56
Inventory Days info
--
4,068.63
204.93
189.72
162.46
148.15
Payable days info
--
75.22
12.73
49.24
90.49
87.75
Cash Conversion Cycle info
--
5,295.94
250.49
190.09
117.76
113.96
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...